81968-020-02 : NDC 2026 Code

81968-020-02 : Meloxicam, Rizatriptan ( Symbravo )

Additionally :

You can get information about “81968-020-02” NDC code in 81968-020-02 in HTML format

HTML | 81968-020-02 in TXT (Plain Text) format

TXT | 81968-020-02 in PDF (Portable Document Format)

PDF | 81968-020-02 in XML format

XML formats.

NDC Code : 81968-020-02 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "81968-020-02",
    "PackageDescription": "1 BOTTLE in 1 CARTON (81968-020-02)  / 2 TABLET in 1 BOTTLE",
    "NDC11Code": "81968-0020-02",
    "ProductNDC": "81968-020",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Symbravo",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Meloxicam, Rizatriptan",
    "DosageFormName": "TABLET",
    "RouteName": "ORAL",
    "StartMarketingDate": "20250519",
    "EndMarketingDate": null,
    "MarketingCategoryName": "NDA",
    "ApplicationNumber": "NDA215431",
    "LabelerName": "Axsome Therapeutics, Inc.",
    "SubstanceName": "MELOXICAM; RIZATRIPTAN BENZOATE",
    "StrengthNumber": "20; 10",
    "StrengthUnit": "mg/1; mg/1",
    "Pharm_Classes": "Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC], Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2025-11-25",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20251121",
    "EndMarketingDatePackage": null,
    "SamplePackage": "Y"
  }
}